Coronavirus Update: Sanofi And GSK’s ‘Tortoise’ Joins Hares In Vaccine Race
Plus: Japan Pledges Support For Covax Initiative
Initial results from the study are expected in early December 2020, which would allow the start of a Phase III trial before the end of the year.
